Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 16;219(5):e20210562. doi: 10.1084/jem.20210562

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Mysore et al.

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

Figure 9. — MHCII⁺ monocytes are present in the urine of patients with active lupus nephritis, and their frequency correlates with disease activity. (A) Cumulative percentage of MHCII^hi cells within the CD14⁺CD163⁺ population in blood from healthy donors (HD) and patients with active lupus nephritis (LN; left) and lupus patients with high and low proteinuria (right). (B) Correlation of percentage of blood MHCII⁺ monocytes and disease index activity (SLEDAI). (C) Cumulative data and representative gating strategy showing the percentages of CD14⁺CD163⁺ cells within the live CD45⁺ cells (left panel) and MHCII^hi cells within the CD14⁺CD163⁺ population in urine from patients with active LN (right panel), separated based on the level of proteinuria (≥532 mg/24 h = high proteinuria). *, P < 0.05. FSC, forward scatter. (D) The correlation of percentage urine MHCII^hi monocytes and SLEDAI is shown.